Vancomycin
- Generic Name
- Vancomycin
- Brand Names
- Firvanq, Vancocin
- Drug Type
- Small Molecule
- Chemical Formula
- C66H75Cl2N9O24
- CAS Number
- 1404-90-6
- Unique Ingredient Identifier
- 6Q205EH1VU
- Background
Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to ristocetin that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear.
...
- Indication
Administered intravenously, vancomycin is indicated in adult and pediatric patients for the treatment of septicemia, infective endocarditis, skin and skin structure infections, bone infections, and lower respiratory tract infections. Administered orally, vancomycin is indicated in adult and pediatric patients for the treatment of Clostridium difficile-associ...
- Associated Conditions
- Clostridium Difficile Associated Diarrhea (CDAD), Enterocolitis caused by Staphylococcus aureus, Infection caused by staphylococci, Severe Staphylococcal infection
- Associated Therapies
- -
Vancomycin-Associated Acute Kidney Injury: A Cross-Sectional Study From a Multi- Center in China
- First Posted Date
- 2018-03-07
- Last Posted Date
- 2019-08-28
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 10000
- Registration Number
- NCT03456544
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
The Effect of an Antibiotic on the Production of Uremic Toxins by the Gut Microbiome
- First Posted Date
- 2018-03-02
- Last Posted Date
- 2021-03-26
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 15
- Registration Number
- NCT03452189
- Locations
- 🇺🇸
New York University School of Medicine, New York, New York, United States
Preoperative Antibiotics for Carpal Tunnel Release Surgery
- Conditions
- Interventions
- First Posted Date
- 2018-02-14
- Last Posted Date
- 2021-11-10
- Lead Sponsor
- WellSpan Health
- Target Recruit Count
- 184
- Registration Number
- NCT03432858
- Locations
- 🇺🇸
WellSpan Surgery and Rehab Hospital, York, Pennsylvania, United States
Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections
- Conditions
- Interventions
- First Posted Date
- 2018-02-08
- Last Posted Date
- 2023-10-03
- Lead Sponsor
- Infectious Diseases Physicians, Inc.
- Target Recruit Count
- 41
- Registration Number
- NCT03426761
- Locations
- 🇺🇸
Infectious Diseases Physicians, Inc., Annandale, Virginia, United States
Microbiota Transfer Therapy for Adults With Autism Spectrum Disorder (ASD) Who Have Gastrointestinal Disorders
- Conditions
- Interventions
- First Posted Date
- 2018-01-24
- Last Posted Date
- 2023-01-09
- Lead Sponsor
- Arizona State University
- Target Recruit Count
- 55
- Registration Number
- NCT03408886
- Locations
- 🇺🇸
Arizona State University, Tempe, Arizona, United States
Prevention of Infections in Cardiac Surgery (PICS) Prevena Study
- Conditions
- Interventions
- First Posted Date
- 2018-01-18
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Population Health Research Institute
- Target Recruit Count
- 4107
- Registration Number
- NCT03402945
- Locations
- 🇨🇦
Hamilton General Hospital, Hamilton, Ontario, Canada
🇨🇦London Health Sciences Centre & Lawson Health Research Institute, London, Ontario, Canada
Study for Antibiotic Impregnated Calcium Sulfate Beads as Prophylaxis for Surgical Site Infection
- Conditions
- Interventions
- First Posted Date
- 2017-10-12
- Last Posted Date
- 2018-07-19
- Lead Sponsor
- McMaster University
- Target Recruit Count
- 60
- Registration Number
- NCT03308253
- Locations
- 🇨🇦
Hamilton General Hospital, Hamilton, Ontario, Canada
Effect of Antibiotics on Gut Microbiome and Plasma Metabolome
- Conditions
- Interventions
- First Posted Date
- 2017-09-06
- Last Posted Date
- 2018-04-04
- Lead Sponsor
- Finnish Institute for Health and Welfare
- Target Recruit Count
- 39
- Registration Number
- NCT03273296
- Locations
- 🇫🇮
National Institute for Health and Welfare, Helsinki, Finland
Treatment of Initial Clostridium Difficile Infection
- Conditions
- Interventions
- First Posted Date
- 2017-04-11
- Last Posted Date
- 2017-04-18
- Lead Sponsor
- Universidad Autonoma de Nuevo Leon
- Target Recruit Count
- 10
- Registration Number
- NCT03107169
Vancomycin Treatment in Recurrent PSC in Liver Transplant Patients
- Conditions
- Interventions
- First Posted Date
- 2017-02-08
- Last Posted Date
- 2019-03-29
- Lead Sponsor
- Ochsner Health System
- Registration Number
- NCT03046901
- Locations
- 🇺🇸
Ochsner Medical Center, New Orleans, Louisiana, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.